Research Topics
| Michael Van AmeringenSummaryAffiliation: McMaster University Country: Canada Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Panic attacks in generalized anxiety disorderMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada
J Nerv Ment Dis 201:52-5. 2013..One in five patients with GAD reported GAD panic attacks; however, these individuals did not differ significantly on the correlates that were evaluated. These findings require replication and further evaluation...
Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]Paul D Carey
MRC Research Unit on Anxiety Disorders, University of Stellenbosch, Cape Town, South Africa
BMC Psychiatry 5:5. 2005..Quetiapine is generally well tolerated and previous open-label data has produced mixed results in OCD and additional controlled data is needed...- Potential use of Internet-based screening for anxiety disorders: a pilot studyMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
Depress Anxiety 27:1006-10. 2010..We posted a self-report diagnostic screening questionnaire for DSM-IV anxiety and mood disorders (MACSCREEN) on our clinic website... 
An evaluation of paroxetine in generalised social anxiety disorderMichael Van Ameringen
Anxiety Disorders Clinic, 3G Clinic, McMaster University Medical Centre, Hamilton Health Sciences, Main St W, Hamilton, ON, L8N 3Z5, Canada
Expert Opin Pharmacother 6:819-30. 2005..The pharmacotherapy of social phobia will be reviewed, with a special focus on investigations with paroxetine...- Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case seriesMichael Van Ameringen
Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
Depress Anxiety 23:1-5. 2006..1 +/- 0.9 to 4.5 +/- 1.3 (P < .001). This case series suggests some preliminary evidence that the addition of topiramate may be useful in treatment-resistant OCD... - Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trialMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
J Clin Psychiatry 68:288-95. 2007..We evaluated the efficacy, safety, and tolerability of nefazodone, a 5-HT(2) antagonist, in patients with generalized social phobia (GSP)... - Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case seriesMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
J Psychopharmacol 21:472-6. 2007..Randomized, double blind, controlled investigations would likely provide useful information as current bioequivalence and pharmacological equivalence do not necessarily translate into clinical equivalence... - The impact of changing diagnostic criteria in posttraumatic stress disorder in a Canadian epidemiologic sampleMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, 439 1 Fontbonne Building, St Joseph s Healthcare Hamilton, 301 James St S, Hamilton, Ontario, Canada L8P 3B5
J Clin Psychiatry 72:1034-41. 2011.... - Pharmacotherapy for social anxiety disorder: an updateMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada
Isr J Psychiatry Relat Sci 46:53-61. 2009..In this article, treatment studies of pharmacotherapy of social phobia are summarized. Additional issues such as comparative efficacy, treatment resistance and relapse-prevention are reviewed... - Adult attention deficit hyperactivity disorder in an anxiety disorders populationMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
CNS Neurosci Ther 17:221-6. 2011..05). The prevalence of adult ADHD was higher in our anxiety disorders clinic sample than found in the general population. Clinical implications of these findings are discussed... - A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomaniaMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
J Clin Psychiatry 71:1336-43. 2010..Trichotillomania has been considered as part of the obsessive-compulsive disorder spectrum; however, trichotillomania treatment with obsessive-compulsive disorder medications has largely been unsuccessful... - Post-traumatic stress disorder in CanadaMichael Van Ameringen
Anxiety Disorders Clinic, McMaster University Medical Centre, Department of Psychiatry and Behavioural Neurociences, McMaster University, Hamilton, Ontario, Canada
CNS Neurosci Ther 14:171-81. 2008..PTSD is a common psychiatric disorder in Canada. The results are surprising, given the comparably low rates of violent crime, a small military and few natural disasters. Potential implications of these findings are discussed... - An open trial of topiramate in the treatment of generalized social phobiaMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
J Clin Psychiatry 65:1674-8. 2004.... - Pharmacotherapy of social anxiety disorder at the turn of the millenniumM Van Ameringen
Anxiety Disorders Clinic, McMaster University Medical Center, Hamilton Health Sciences, Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
Psychiatr Clin North Am 24:783-803. 2001..quot; The current established treatments need to be evaluated further in this geriatric population... - Topiramate treatment for SSRI-induced weight gain in anxiety disordersMichael Van Ameringen
Anxiety Disorders Clinic, McMaster University Medical Centre, Hamilton, ON, Canada
J Clin Psychiatry 63:981-4. 2002..In this study, topiramate was added to the treatment regimen of patients with a primary DSM-IV anxiety disorder who had experienced substantial SSRI-induced weight gain, in an attempt to induce weight loss... - Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled studyM A Van Ameringen
Anxiety Disorders Clinic, McMaster University Medical Centre, Hamilton, Canada
Am J Psychiatry 158:275-81. 2001..The authors evaluated the efficacy, safety, and tolerability of sertraline, a selective serotonin reuptake inhibitor, in the treatment of generalized social phobia... - The impact of anxiety disorders on educational achievementMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont, Canada L8N 3Z5
J Anxiety Disord 17:561-71. 2003..Further studies are required to determine methods for early identification and treatment of anxiety disorders in school aged children to enable these students to reach their full potential... - Predictors of response in generalized social phobia: effect of age of onsetMichael Van Ameringen
Anxiety Disorders Clinic, McMaster University Medical Centre, McMaster University, Hamilton, Ontario, Canada
J Clin Psychopharmacol 24:42-8. 2004..This advantage for later-onset GSP can be accounted for neither by severity of illness nor by duration of illness. Superior treatment outcome for later-onset GSP may be mediated by the degree of social and family disability... - WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen
Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
CNS Spectr 8:40-52. 2003..In light of the chronicity and disability associated with social phobia, as well as the high relapse rate after short-term therapy, it is recommended that effective treatment be continued for at least 12 months... - A PET provocation study of generalized social phobiaMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada L8N 3Z5
Psychiatry Res 132:13-8. 2004..Deactivation of these regions may reflect a strategy of visual avoidance employed by the patients to dampen their phobic experience... - Antiepileptic drugs in the treatment of anxiety disorders: role in therapyMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
Drugs 64:2199-220. 2004.... - Optimizing treatment in social phobia: a review of treatment resistanceMichael Van Ameringen
Department of Psychiatry and Behavioural Neurosciences at McMaster University, Hamilton, Ontario, Canada
CNS Spectr 9:753-62. 2004..Our current treatment target of simply attaining a response needs to be refocused, so that an asymptomatic state and high end state functioning become the final goal of treatment... - Frontal brain oscillatory coupling in children of parents with social phobia: a pilot studyVladimir Miskovic
McMaster Integrative Neuroscience Discovery and Study, McMaster University in Hamilton, Ontario, Canada
J Neuropsychiatry Clin Neurosci 23:111-4. 2011.... - Trichotillomania in youth: a retrospective case seriesCatherine Mancini
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Ontario, Canada
Depress Anxiety 26:661-5. 2009..The purpose of this study was to investigate the outcome of the naturalistic treatment of youth with Trichotillomania (TTM) in an anxiety disorders clinic sample... - Emerging treatments for child and adolescent social phobia: a reviewCatherine Mancini
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
J Child Adolesc Psychopharmacol 15:589-607. 2005..Several studies on the use of cognitive behavioral therapy in youths will also be examined. Practical guidelines for clinicians who treat children and adolescents are also presented... - The prevalence of migraine headaches in an anxiety disorders clinic sampleRhandi Senaratne
Department of Psychology, Faculty of Science, McMaster University, Hamilton, Ontario, Canada
CNS Neurosci Ther 16:76-82. 2010..Further research is required to better understand the nature and implications of the association between migraine and psychiatric disorders... - Does SSRI augmentation with antidepressants that influence noradrenergic function resolve depression in obsessive-compulsive disorder?Catherine Mancini
Anxiety Disorders Clinic, McMaster University Medical Centre, Hamilton Health Sciences Corporation, McMaster Site, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5
J Affect Disord 68:59-65. 2002..However, such is not always the case. We report here on a series of ten patients whose OCD but not depression improved following a trial of SRI therapy... 
When too much is not enough: obsessive-compulsive disorder as a pathology of stopping, rather than startingAndrea L Hinds
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
PLoS ONE 7:e30586. 2012....- The burden of anxiety disorders on the familyRhandi Senaratne
Department of Medical Sciences, McMaster University, Hamilton, Ontario, Canada
J Nerv Ment Dis 198:876-80. 2010..Health-care professionals should assess the impact of anxiety disorders on the patient's family and provide interventions to reduce burden and improve the quality of life of family members... - A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety ScaleJonathan Oakman
Psychology Department, University of Waterloo, Ontario, Canada
J Clin Psychol 59:149-61. 2003..We argue in favor of adopting the 4-factor model for the LSAS proposed by Safren et al. (1999) instead of the models implied by the scoring instructions for the LSAS... - The psychology of potential threat: properties of the security motivation systemAndrea L Hinds
Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1200 Main St W, Hamilton, ON, Canada L8N 3Z5
Biol Psychol 85:331-7. 2010..These findings are consistent with the hypothesis that deactivation of the security motivation system depends on performance of security-related behaviors, rather than non-behavioral events such as cognitive re-evaluation of threat... - Behavioral and psychophysiological characteristics of children of parents with social phobia: a pilot studyMira J Campbell
Department of Psychology, Neuroscience and Behaviour, McMaster University, Hamilton, Ontario, Canada
Int J Neurosci 117:605-16. 2007.... - Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: is response to treatment predictable?Paul D Carey
Department of Psychiatry, University of Stellenbosch, Tygerberg
Int Clin Psychopharmacol 27:321-5. 2012..Other factors are, however, also likely to play an important role in predicting outcome...
Research Grants
- Improving Outcomes in Pharmacotherapy of Social PhobiaMichael Van Ameringen; Fiscal Year: 2009..It thus directly addresses a critical public health issue that adversely affects a substantial proportion of the population. ..
- Improving Outcomes in Pharmacotherapy of Social PhobiaMichael Van Ameringen; Fiscal Year: 2007..It thus directly addresses a critical public health issue that adversely affects a substantial proportion of the population. ..